Table 2.

Molar ratios of lipids to apoA-I in the four HDL subfractions. Data in the first row are mean lipid to apoA-I molar ratios +/− SD. The second row of each analyte shows the significance values from a post-hoc pairwise comparison versus the E-CIII- fraction. The third row of each analyte shows the proportion of each lipid in that fraction as a percentage of the total mass of such lipid in HDL. The last row shows the significance value from a global one-way ANOVA for the analysis of lipid to apoA-I molar ratios by subfractions

		E-CIII-	E + CIII-	E-CIII+	E + CIII+
Triglycerides	to apoA-I molar ratio	0.47 +/− 0.22	1.09 +/− 1.41	2.73 +/− 3.48	2.41 +/− 1.87
	p-value versus E-CIII-	–	0.88	0.035	0.09
	% of total mass in HDL	25.2%	17.2%	29.8%	27.7%
	p-value from ANOVA	0.01
Cholesterol	to apoA-I molar ratio	26.6 +/− 18.7	51.5 +/− 68.4	48.1 +/− 32	52.6 +/− 38.1
	p-value versus E-CIII-	–	0.43	0.55	0.39
	% of total mass in HDL	40.7%	22.5%	20.8%	15.8%
	p-value from ANOVA	0.26
Phosphatidylcholine	to apoA-I molar ratio	109.2 +/− 69.3	317.6 +/− 367.7	455.7 +/− 547.3	488.2 +/− 669.2
	p-value versus E-CIII-	–	0.65	0.21	0.15
	% of total mass in HDL	27.1%	27.0%	26.0%	19.7%
	p-value from ANOVA	0.088
Cholesterol esters	to apoA-I molar ratio	14.6 +/− 16	23 +/− 29.9	16.3 +/− 37.9	30 +/− 103
	p-value versus E-CIII-	–	0.98	0.99	0.89
	% of total mass in HDL	48.6%	28.8%	12.3%	10.1%
	p-value from ANOVA	0.86